COMMUNIQUÉS West-GlobeNewswire

Humacyte First Quarter 2024 Financial Results and Business Update
10/05/2024
-Biologics License Application (BLA) for HAV™ Accepted by FDA- -BLA Granted Priority Review for Vascular Trauma Indication; PDUFA date set for August 10, 2024- -Raised approximately $43 million in net proceeds from [...]
Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
10/05/2024
In vitro data showcases CNTY-101’s ability to induce CD19-specific cytolysis of B-cells and potential to treat B-cell driven autoimmune diseases including systemic lupus erythematosus (SLE) Preclinical data demonstrates [...]
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
10/05/2024
TAMPA, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced the pricing of $250.0 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a [...]
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
10/05/2024
Generated record quarterly net revenues of $137.4 million, representing year-over-year growth of 28.7% , net income to common shareholders of $17.8 million, and GAAP diluted earnings per share of $0.82 Delivered record [...]
Le TAR-200 en monothérapie montre un taux de réponse complète supérieur à 80 pour cent chez les patients atteints d’un cancer de la vessie n’infiltrant pas le muscle à haut risque
10/05/2024
Les nouvelles données issues de l’étude de Phase IIb SunRISe-1 montrent l’obtention rapide d’une réponse complète (RC), 98 pour cent des patients ayant présenté une RC dans les 12 semaines 1 Le TAR-200 permet d’obtenir [...]
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
10/05/2024
Fueling the diagnosis of over 2,500 rare and neurodegenerative diseases, more than 300 peer-reviewed publications, and 48 pharma collaborations CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, May 10, 2024 (GLOBE [...]
Tome Biosciences Presented Data on its Programmable Genomic Integration Technologies at ASGCT
10/05/2024
Achieved therapeutically-relevant targeted gene integration and functional protein expression in vivo in non-human primates Demonstrated efficient multiplex editing and integration of large DNA sequences with functional [...]
Tessera Therapeutics Presents New Preclinical Data Highlighting Advancements Across Its Portfolio Programs and Platforms at the American Society of Gene and Cell Therapy 27th Annual Meeting
10/05/2024
Gene Writing™ platform demonstrates highly efficient in vivo correction of mutation responsible for alpha-1 antitrypsin deficiency (AATD) to wild-type Combination of proprietary lipid nanoparticle (LNP) delivery to long [...]
Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting
10/05/2024
Research includes the first-ever application of AsCas12a in vivo , optimized LNP delivery, and gene editing RNA guide modifications Data to support development of the Company’s in vivo gene editing medicines pipeline [...]
IBA : 2024 AGM - Convening Notice
10/05/2024
Cher Actionnaire, Nous avons l’honneur de vous convoquer à l’Assemblée Générale Ordinaire (l’« AGO » ) des actionnaires d’IBA qui se tiendra le mercredi 12 juin 2024 à 10h00 , pour délibérer sur l’ordre du jour détaillé [...]
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
10/05/2024
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Agreement provides patients with broader access to a protein-based [...]
Communiqué de presse : Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19
10/05/2024
Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19 L’accord, qui combinera la puissance commerciale [...]
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024
10/05/2024
REGULATED INFORMATION May 10, 2024, 7:00am CET / 1:00am ET NYXOAH SA (Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (hereinafter the “ Company ”) Invitation to attend the annual and the [...]
Invitation à assister à l'assemblée générale annuelle et extraordinaire des actionnaires de la Société qui se tiendra le 12 juin 2024
10/05/2024
INFORMATIONS RÉGLEMENTÉES le 10 mai 2024, 7:00h CET / 1:00h ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgique (ci-après la « Société ») Invitation à assister à l' [...]
Ibogaine Software Serves as a Memoir to a Family Owned and Operated Business
10/05/2024
Ibogaine Research Center Works to Perfect New Software to Continue The Legacy of David Dardashti MIAMI, May 09, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a family run business, has worked for the past 10 [...]
Corza Medical nommée « Meilleure société à l’échelle mondiale dans le domaine des technologies médicales » lors de la 8e édition du programme annuel des MedTech Breakthrough Awards
10/05/2024
Le prestigieux programme international de remise de prix organisé chaque année récompense les produits et entreprises qui se sont démarqués sur le plan de la santé numérique et des technologies médicales WESTWOOD, Mass [...]
Inotiv, Inc. Reschedules its Fiscal 2024 Second Quarter Results
10/05/2024
WEST LAFAYETTE, Ind., May 09, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development [...]
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
10/05/2024
PLEASANTON, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that four independent scientific abstracts accepted for the [...]
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2024 Financial Results on May 15, 2024
10/05/2024
FREDERICK, Md., May 09, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report [...]

Pages